312 related articles for article (PubMed ID: 20053755)
1. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.
Sasu BJ; Cooke KS; Arvedson TL; Plewa C; Ellison AR; Sheng J; Winters A; Juan T; Li H; Begley CG; Molineux G
Blood; 2010 Apr; 115(17):3616-24. PubMed ID: 20053755
[TBL] [Abstract][Full Text] [Related]
2. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
Roy CN; Mak HH; Akpan I; Losyev G; Zurakowski D; Andrews NC
Blood; 2007 May; 109(9):4038-44. PubMed ID: 17218383
[TBL] [Abstract][Full Text] [Related]
3. A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates.
Cooke KS; Hinkle B; Salimi-Moosavi H; Foltz I; King C; Rathanaswami P; Winters A; Steavenson S; Begley CG; Molineux G; Sasu BJ
Blood; 2013 Oct; 122(17):3054-61. PubMed ID: 23945155
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus.
Gardenghi S; Renaud TM; Meloni A; Casu C; Crielaard BJ; Bystrom LM; Greenberg-Kushnir N; Sasu BJ; Cooke KS; Rivella S
Blood; 2014 Feb; 123(8):1137-45. PubMed ID: 24357729
[TBL] [Abstract][Full Text] [Related]
5. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin.
Kim A; Fung E; Parikh SG; Valore EV; Gabayan V; Nemeth E; Ganz T
Blood; 2014 Feb; 123(8):1129-36. PubMed ID: 24357728
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.
Ganz T
Blood; 2003 Aug; 102(3):783-8. PubMed ID: 12663437
[TBL] [Abstract][Full Text] [Related]
7. Erythroferrone contributes to recovery from anemia of inflammation.
Kautz L; Jung G; Nemeth E; Ganz T
Blood; 2014 Oct; 124(16):2569-74. PubMed ID: 25193872
[TBL] [Abstract][Full Text] [Related]
8. Late stage erythroid precursor production is impaired in mice with chronic inflammation.
Prince OD; Langdon JM; Layman AJ; Prince IC; Sabogal M; Mak HH; Berger AE; Cheadle C; Chrest FJ; Yu Q; Andrews NC; Xue QL; Civin CI; Walston JD; Roy CN
Haematologica; 2012 Nov; 97(11):1648-56. PubMed ID: 22581006
[TBL] [Abstract][Full Text] [Related]
9. Low hepcidin accounts for the proinflammatory status associated with iron deficiency.
Pagani A; Nai A; Corna G; Bosurgi L; Rovere-Querini P; Camaschella C; Silvestri L
Blood; 2011 Jul; 118(3):736-46. PubMed ID: 21628413
[TBL] [Abstract][Full Text] [Related]
10. Hepatic hypoxia-inducible factor-2 down-regulates hepcidin expression in mice through an erythropoietin-mediated increase in erythropoiesis.
Mastrogiannaki M; Matak P; Mathieu JR; Delga S; Mayeux P; Vaulont S; Peyssonnaux C
Haematologica; 2012 Jun; 97(6):827-34. PubMed ID: 22207682
[TBL] [Abstract][Full Text] [Related]
11. Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide.
Darshan D; Frazer DM; Wilkins SJ; Anderson GJ
Haematologica; 2010 Oct; 95(10):1660-7. PubMed ID: 20511664
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate treatment of acute anemia of inflammation in a mouse model.
Kim A; Fung E; Parikh SG; Gabayan V; Nemeth E; Ganz T
Blood Cells Mol Dis; 2016 Jan; 56(1):31-6. PubMed ID: 26603720
[TBL] [Abstract][Full Text] [Related]
13. [Iron metabolism: State of the art].
Beaumont C; Karim Z
Rev Med Interne; 2013 Jan; 34(1):17-25. PubMed ID: 22595534
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia.
Rivera S; Liu L; Nemeth E; Gabayan V; Sorensen OE; Ganz T
Blood; 2005 Feb; 105(4):1797-802. PubMed ID: 15479721
[TBL] [Abstract][Full Text] [Related]
15. High-throughput screening of small molecules identifies hepcidin antagonists.
Fung E; Sugianto P; Hsu J; Damoiseaux R; Ganz T; Nemeth E
Mol Pharmacol; 2013 Mar; 83(3):681-90. PubMed ID: 23292796
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation.
Jain M; Joharapurkar A; Patel V; Kshirsagar S; Sutariya B; Patel M; Patel H; Patel PR
Eur J Pharmacol; 2019 Jan; 843():113-120. PubMed ID: 30458168
[TBL] [Abstract][Full Text] [Related]
17. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.
Nicolas G; Chauvet C; Viatte L; Danan JL; Bigard X; Devaux I; Beaumont C; Kahn A; Vaulont S
J Clin Invest; 2002 Oct; 110(7):1037-44. PubMed ID: 12370282
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin and iron-loading anemias.
Nemeth E; Ganz T
Haematologica; 2006 Jun; 91(6):727-32. PubMed ID: 16769573
[No Abstract] [Full Text] [Related]
19. Hepcidin and disorders of iron metabolism.
Ganz T; Nemeth E
Annu Rev Med; 2011; 62():347-60. PubMed ID: 20887198
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease.
Song SN; Tomosugi N; Kawabata H; Ishikawa T; Nishikawa T; Yoshizaki K
Blood; 2010 Nov; 116(18):3627-34. PubMed ID: 20644113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
